This inventor holds 7 USPTO granted patents and 2 published patent applications. Top assignee: Columbia University. Active years: 2021-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021-2025
Title: Min-Kang Hsieh: Innovator in Nucleotide Derivatives
Introduction
Min-Kang Hsieh is a prominent inventor based in New York, NY (US). He has made significant contributions to the field of nucleic acid sequencing through his innovative patents. With a total of 7 patents, Hsieh's work has advanced the methodologies used in genetic research and biotechnology.
Latest Patents
Among his latest patents, Hsieh has developed groundbreaking technologies such as "Nucleotide derivatives and methods of use thereof." This patent discloses compounds, compositions, and methods that facilitate the sequencing of nucleic acids. Another notable patent is "Synthesis of novel disulfide linker based nucleotides as reversible terminators for DNA sequencing by synthesis." This invention also focuses on compounds and methods that enhance nucleic acid sequencing techniques.
Career Highlights
Min-Kang Hsieh is affiliated with Columbia University, where he continues to push the boundaries of research in his field. His work has garnered attention for its potential applications in various scientific and medical domains.
Collaborations
Hsieh collaborates with esteemed colleagues such as Jingyue Ju and Xiaoxu Li, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Min-Kang Hsieh's contributions to nucleotide derivatives and sequencing methods exemplify the impact of innovative thinking in biotechnology. His patents not only reflect his expertise but also pave the way for future advancements in genetic research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
